NEJM Journal Watch Emergency Medicine Top Stories of 2018

A perspective on the most important research in the field from the past year

Dear Readers,

This year has been marked by the insanity of the opioid epidemic, but there have been significant advances on less sensational topics. A much more nuanced approach to care of patients with pulmonary embolism has emerged, with selective anticoagulation, outpatient management, and improved use of the d-dimer assay. We continue to hone our approach to neuroimaging, as research identifies more and more patients who don't require these expensive scans. We end our top-10 list with some very surprising practice-changing research on magnesium and ondansetron.

The top NEJM Journal Watch Emergency Medicine stories for 2018 are:

Author

Daniel J. Pallin, MD, MPH

Disclosures

Consultant/Advisory BoardPortola Pharmaceuticals, Inc.

Speaker’s BureauPeerView Institute for Medical Education

Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals

Daniel J. Pallin, MD, MPH

Disclosures

Consultant/Advisory BoardPortola Pharmaceuticals, Inc.

Speaker’s BureauPeerView Institute for Medical Education

NEJM Journal Watch Emergency Medicine Top Stories of 2018

Topics

Author